MedPath

Effect of CVP and IOH on AKI and AKD

Completed
Conditions
Acute Kidney Injury
Acute Kidney Disease
Interventions
Other: Introperation hypotension
Other: Venous congestion
Registration Number
NCT05222074
Lead Sponsor
Nanjing First Hospital, Nanjing Medical University
Brief Summary

This study was aimed to explore the effect of intraoperative venous congestion and intraoperative hypotension (IOH) on acute adverse kidney events, defined as acute kidney injury (AKI) and acute kidney disease (AKD), after cardiac surgery

Detailed Description

Venous congestion and IOH were primary exposures and quantified as area under the curve (AUC) of central venous pressure ≥12, 16 or 20 mmHg or mean arterial pressure ≤55, 65, 75 mmHg. The primary outcome was AKI or AKD defined as renal dysfunction persisting \> 7 days after surgery. Multivariable logistic regression and Cox proportional hazard models were used to determine the association between intraoperative venous congestion/hypotension and postoperative acute adverse kidney events, respectively, adjusted for relevant confounding factors and multiple comparisons.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
5127
Inclusion Criteria
  • Patients aged 18 years and older,
  • Patients underwent cardiac surgery (coronary artery bypass grafting, heart valve surgery, heart transplant or surgical excision of intracardiac myxoma)
  • Patients receiving invasive intraoperative BP monitoring during surgery
  • Patients underwent cardiopulmonary bypass (CPB) during surgery
Exclusion Criteria
  • Pre-existing renal insufficiency defined by presence of abnormal preoperative serum creatinine ≥ 133 μmol/L and/or preoperative diagnosis of renal insufficiency within 6 months'preoperative period.
  • Patients with preoperative dialysis dependence within 60 days before the index surgical procedure,
  • Surgical duration less than 30 minutes
  • Surgery on the aorta
  • Insufficient hemodynamic and laboratory data for outcomes and/or exposure ascertainment

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
MAP ≤ 65 mmHgIntroperation hypotensionmean arterial pressure ≤65 mmHg
CVP ≥ 16Venous congestioncentral venous pressure ≥16 mmHg
CVP ≥ 12Venous congestioncentral venous pressure ≥12 mmHg
MAP ≤ 75 mmHgIntroperation hypotensionmean arterial pressure ≤75 mmHg
CVP ≥ 20Venous congestioncentral venous pressure ≥20 mmHg
MAP ≤ 55 mmHgIntroperation hypotensionmean arterial pressure ≤55 mmHg
Primary Outcome Measures
NameTimeMethod
AKD8 to 90 days post operation

Acute Kidney Disease, which was defined according to the criteria recommended by the Acute Disease Quality Initiative (ADQI) workgroup.4 AKI was quantified within the 7 days' postoperative period, while AKD was defined as serum creatinine value elevated to 1.5 times the baseline value between 8- and 90-day post-operation period.

CSA-AKI7 days post operation

Cardiovascular surgery associated acute kidney injury. AKI was defined using the Kidney Disease: Improving Global Outcome (KDIGO) Clinical Practice Guideline for Acute Kidney Injury as an absolute increase in serum creatinine of ≥ 26 μmol/L within 48 hours or an increase in serum creatinine beyond 1.5 times the baseline value within 7 days

Secondary Outcome Measures
NameTimeMethod
inpatient mortality30 days after inhospital

mortality during hospital stay

Incidence of AKD of stage 2 and above8 to 90 days post operation

incidence of AKD of stage 2 and above, defined as increase in serum creatinine beyond 2.0 times the baseline value between 8- and 90-day post-operation period.

length of hospital stayfrom the end of operation to the discharge from hospital, up to 90 days.

days stay in hospital

RRT initiationfrom the end of operation to the discharge from hospital, up to 90 days.

renal replacement theray (RRT) initiation

value of eGFR7 days after operation

postoperative estimated glomerular filtration rate (eGFR), which was calculated by MDRD Equation.

ICU length of stayfrom the end of operation to the discharge from ICU, up to 90 days.

days stay in ICU

Trial Locations

Locations (1)

Nanjing First Hospital

🇨🇳

Nanjing, Jiangsu, China

© Copyright 2025. All Rights Reserved by MedPath